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INTRODUCTION:Gangliocytic paraganglioma is a rare tumor that ismost commonly located in the duode-
num. At presentation, itmay be confusedwith a gastrointestinal stromal tumor (GIST), but distinguishing
between these tumors is critical because the natural history and treatment of these two tumors dif-
fers markedly. Duodenal gangliocytic paraganglioma typically exhibits benign behavior with occasional
regional lymph node metastasis and no reports of tumor associated deaths. Recurrence after resection is
rare.
PRESENTATION OF CASE: A 50 year-old male presented with melena and hemoglobin concentration of
4.6 g/dl. Esophagogastroduodenoscopy demonstrated a submucosal mass in the third portion of the duo-
denum with no active bleeding. CT scan identiﬁed no regional lymphadenopathy or distant metastasis.
The tumor was resected through a longitudinal duodenotomy with negative margins.
DISCUSSION: Endoscopic resection of duodenal gangliocytic paraganglioma appears to be safe and effec-
tive when tumor may be removed in its entirety by this method. If the tumor is not suspended by a stalk
or there is suspicion for regional lymph node disease then surgical management is preferred. Radiation
oncologists at high volume centers have endorsed utilization of adjuvant radiotherapy to the postsurgi-
cal bed in cases involving lymph node metastasis. Utilization of chemotherapy for management of this
disease has not been reported.
CONCLUSION: Localized duodenal gangliocytic paragangliomas are best managed by resection with neg-
ative margins. In cases in which the tumor is resected with negative margins, it appears to be safe to
embark on a course of surveillance and forego adjuvant therapy.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/).
1. Introduction
Gangliocytic paraganglioma is a rare tumor that is located in
the duodenum in 90% of cases with a particular predilection to
the region of the ampulla of Vater [1]. At presentation, it may be
confused with a gastrointestinal stromal tumor (GIST), but distin-
guishing these tumors is critical because the natural history, and
therefore, treatment of these two tumors differs markedly. About
200 cases have been reported since the ﬁrst description of this
tumor in 1957 [2]. Themost common clinical presentation includes
melena and abdominal pain, each of which occurs in about half
of all patients [1]. This tumor typically exhibits benign behavior
with regional lymph node metastasis occurring in only 5–7% of
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caseswithno tumorassociateddeaths reported [1,3–8]. Recurrence
after resection is rare, with only a single reported recurrencemany
years after initial resection [9]. Herein, we report a case of surgi-
cally resected duodenal gangliocytic paraganglioma and review the
pertinent literature.
2. Exemplary patient
A50year-oldmalepresented to anoutsidehospitalwithmelena
and hemoglobin concentration of 4.6 g/dl. He received a total of
four units of packed red blood cells and underwent esophagogas-
troduodenoscopy, which demonstrated a submucosal mass in the
third portion of the duodenum with no active bleeding. Computed
tomography visualized a 2.5 cm duodenal mass with no evidence
of regional lymphadenopathy or distant metastasis. He was trans-
ferred to our facility for consideration of a pancreatoduodenectomy
due to the close proximity of the mass to the superior mesenteric
artery and vein.
http://dx.doi.org/10.1016/j.ijscr.2015.01.003
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/4.0/).
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Fig. 1. (A) Hematoxylin and eosin-stained section shows a circumscribed submu-
cosal mass with spindle cells arranged in nests and trabeculae. (B) Rare ganglion
cells were identiﬁed, scattered within the spindle cell compartment.
Exploratory laparotomy conﬁrmed the absence of distant dis-
ease and regional lymphadenopathy. The mass was mobile within
the third portion of the duodenum, and it appeared amenable
to local resection. Through a longitudinal duodenotomy, a 2.5 cm
mobile tumor was delivered and noted to be suspended on a wide
mucosal stalk. A linear cutting stapler was used to transect the
base of the stalk, and the tumor was removed with a clear mar-
gin. Initial frozen section pathological assessment of the mass was
consistent with a GIST. The duodenotomy was closed transversely
in two layers.
Postoperatively, the patient did well with no complications and
was discharged on postoperative day ﬁve. He returned to clinic
tolerating his diet without evidence of ongoing bleeding.
3. Pathology review
Histologic evaluation revealed a well-circumscribed, non-
encapsulated tumor based in the submucosa and muscularis
propria of the duodenum (Fig. 1A). The tumor was predominantly
composed of spindled cells arranged in a nested/trabecular pattern.
Only rare scattered ganglion-like cells were identiﬁed (Fig. 1B).
Areas of the tumor show palisaded arrangements of spindled cells
resembling Verocay bodies, classically found in schwannomas, yet
also described in some GISTs. Epithelioid cells arranged in nests
(so called “endocrine” pattern) were not identiﬁed. A deﬁnitive
epithelioid-endocrine component was not apparent. The tumor
was immunoreactive for neuron-speciﬁc enolase, chromogranin
and S-100 highlighted sustentacular cells. The tumor displayed a
relatively low mitotic rate of 2/10HPF, conﬁrmed by immunostain
for phosphohistone-H3 (PHH3). The overlying small bowelmucosa
demonstrated ulceration and reactive epithelial changes includ-
ing foveolar metaplasia. The morphologic ﬁndings, along with the
immunohistochemical proﬁle, support a diagnosis of gangliocytic
paraganglioma.
Due to its spindle-cell predominance, ourmaindifferential diag-
nosis included nerve sheath tumors (schwannoma) and GIST. The
lack of diffuse positivity for S-100 and the presence of scattered
ganglion cells excluded the possibility of a schwannoma, a very
rare tumor in this location. Negative immunohistochemical stains
for DOG-1, CD117 and CD34 as well as the sustentacular pattern of
S-100 (Table 1) protein argued against a GIST.
4. Discussion
Duodenal gangliocytic paraganglioma consists of three distinct
cellular elements: spindle cells, epithelial cells originating from the
ventral primordium of the pancreas, and ganglion cells [3,4,10].
The proportion of these three cell types is variable. In spindle-cell
predominant tumors, the differential diagnosis includes schwan-
nomas and GIST. If there is a predominance of ganglion cells or
epithelioid cells, the differential diagnosis includes ganglioneuro-
mas for the former andwell-differentiated neuroendocrine tumors
or carcinomas for the latter. These tumors range in size from0.5 cm
to 10 cm and average 2.5 cm in largest diameter [1,4,5]. The neo-
plasms most often affect individuals ranging from the second to
the ninth decade of life and exhibit a slight male predominance
with a ratio of 1.5:1 [1]. Gangliocytic paraganglioma appears on
ultrasound as an isoechoic mass and on computed tomography
as a homogenously iso-attenuated mass [6]. Due to the submu-
cosal location of this tumor, preoperative pathologic diagnosis is
difﬁcult based on endoscopic biopsy alone [5]. Tumor behavior
is usually benign with regional lymph node metastasis occurring
in about 5–7% of cases [1,3–8,11,12] with rare invasion of nearby
structures [13]. Younger patients appear to be at increased risk for
lymph node metastasis [1]. Recurrence is rare, and has occurred
as late as 11 years after initial resection [9]. Although ganglio-
cytic paraganglioma from primary sites other than the duodenum
have demonstrated the potential for distant metastasis [14], there
have beenno reported cases of distantmetastasis fromgangliocytic
paraganglioma of duodenal origin [1–5,7–11]. Although there are
isolated cases of gangliocytic paragangliomas in association with
neuroﬁbromatosis, the vast majority of these cases are sporadic
[15].
Endoscopic resection of duodenal gangliocytic paraganglioma
appears to be safe and effective in cases in which the tumor
may be removed in its entirety by endoscopic methods [1,4,5].
One case has been reported in which a positive margin follow-
ing endoscopic resection was managed with pylorus preserving
pancreaticoduodenectomy [11]. Pathologic review of the pancre-
aticoduodenectomy specimen identiﬁedmetastasis in 2 of 7 lymph
nodes, indicating the aggressive nature of this particular tumor.
Surprisingly, this tumor was only 1.5 cm in its greatest dimension.
Eight cases of surgically resected duodenal gangliocytic paragan-
glioma are listed in Table 2. Of note, the patients with lymph node
metastases appeared to have epithelial components in the tumor.
Whether this is coincidence or indicative of a causal relationship
is unknown. In our case, surgical resection through a duodeno-
tomywasperformedwithout complicationandachievedanegative
margin.
Radiation oncologists at high volume centers have endorsed uti-
lization of adjuvant radiotherapy to the postsurgical bed in cases
involving lymph node metastasis [3]. There has not been a doc-
umented recurrence of duodenal gangliocytic paraganglioma in
patients who harbor no residual disease after initial resection, and
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Table 1
Immunohistochemistry staining characteristics of spindle-cell predominant duodenal tumors.
NSE Chromogranin S-100 CK-PAN DOG-1 CD117
(c-Kit)
CD34
Gangliocytic
paraganglioma
+
(All 3 cell types)
+
(Mostly
described in
epithelial
component)
+
(Spindle cell
component)
+
50% of cases
(Only epithelioid
component)
− − −
Schwannoma +/–
(+ In approx 25%
of cases)
– +
(Strong and
diffusely
positive)
– – – –
(Rare cases show
focal positivity)
GIST – – Mostly –
(5% focal
positivity)
– +
(>90%)
+
(>90%)
+
(66%)
NSE: Neuron-speciﬁc enolase.
CK-Pan: Pancytokeratin.
DOG-1: Discovered on GIST.
Table 2
Characteristics of surgically resected duodenal gangliocytic paragangliomas.
Case Presentation Size Location Management Components Behavior
Dahl et al. [2] Abdominal
discomfort
1.2 cm 2nd Portion of
duodenum
Surgical local excision Unmyelinated nerve
ﬁbers
No regional involvement
Wong et al. [3] RUQ pain 1.4 cm Ampulla of Vater Whipple procedure Epithelial,
neuroﬁbrillary, and
stromal cells
6 of 7 lymph nodes positive
Sundararajan et al. [4] Surveillance EGD 5cm 2nd Portion of
duodenum
Whipple procedure Epithelioid, spindle,
and ganglion cells
1 of 2 lymph nodes positive
Kwon et al. [5] Melena 2.5 cm Ampulla of Vater Whipple procedure Endocrine, spindle, and
ganglion cells
No regional involvement
Shi et al. [8] LLQ pain 4 cm Ampulla of Vater Whipple procedure Epithelial, spindle, and
ganglion cells
8 of 12 lymph nodes positive
Witkiewicz et al. [11] RUQ pain 1.5 cm 2nd portion of
duodenum
Endoscopic resectiona Epithelioid, spindle,
and ganglion cells
2 of 7 lymph nodes positive
Cecka et al. [12] Positive fecal
occult blood test
1.8 cm 2nd portion of
duodenum
Removal through
duodenotomy
Spindle and ganglion
cells
No regional involvement
Our case Melena 2.5 cm 3rd Portion of
duodenum
Removal through
duodenotomy
Spindle and ganglion
cells
No regional involvement
a This patient initially underwent endoscopic resection for which pathologic examination of the specimen demonstrated tumor extending to themargin and subsequently
underwent a Whipple procedure.
adjuvant therapy appears to be unnecessary in such cases [1,4,9].
Utilization of chemotherapy for management of this disease has
not been reported. Information regarding long term outcomes is
limited by the rare nature of this tumor. Following discussion of
this case at our multidisciplinary tumor board, we plan to perform
annual surveillance.
5. Conclusion
Localized duodenal gangliocytic paragangliomas may be con-
fused with GIST and are best managed by resection with negative
margins. Endoscopic removal is safe and effective in cases in which
the tumor is suspended by a stalk and local and regional disease
is absent. For all other cases, surgical resection is recommended.
In cases in which the tumor is resected with negative margins, it
appears to be safe to embark on a course of surveillance and forego
adjuvant therapy.
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